Metaphylaxis Under Pressure: What’s Next for BRD Management?
The first few days in a feedlot ask a lot of a calf. Transportation, grouping, a new diet, and a different environment on top of recent weaning and other management changes make receiving a critical period for cattle health. There is a lot of uncertainty and animals are at high risk of the possibility of developing bovine respiratory disease (BRD).
For many feedlots, metaphylaxis remains an important part of managing that uncertainty. Treating an at-risk group of cattle helps reduce respiratory disease and gives newly arrived animals time to acclimate. However, rising treatment costs, concerns about additional handling stress, and increasing scrutiny of antibiotic use and antimicrobial resistance are putting pressure on the industry to identify alternative approaches.
The challenge is not simply to use fewer antibiotics. It is to use them more precisely without giving up the animal-health benefits that make metaphylaxis valuable in the first place.
Metaphylaxis has substantial evidence.
The performance case for metaphylaxis is well documented. In a Texas A&M study of 198 high-risk male calves, cattle receiving metaphylaxis upon arrival with either ceftiofur (Naxcel) or tilmicosin (Micotil) had a 25.2% lower respiratory morbidity than untreated controls (51.5% vs. 76.7%). Treated calves also gained faster and more efficiently during the first two weeks on feed and took five days longer on average to require their first therapeutic treatment (10 vs. 5 days).
A second trial with 238 multiple-sourced, high-risk steers compared saline control against florfenicol (Nuflor), ceftiofur (Naxcel), and tulathromycin (Draxxin) metaphylaxis. Tulathromycin and ceftiofur cut first BRD treatment rates to 26.3% versus 58.8% for controls, and tulathromycin improved overall receiving-period average daily gain by 49% compared with no metaphylaxis (1.36 vs. 1.04 kg/day).
As West Texas A&M's John Richeson describes it, “metaphylaxis is more than administering a drug—it is part of a broader strategy to control disease while high-risk cattle adjust to the feedyard”.
Does metaphylaxis increase or decrease total antibiotic use?
One of the most interesting findings from work at Texas A&M looks at total antimicrobial use. Despite mass-treating every animal on arrival, the total mass of antibiotic active ingredient per animal was essentially the same for metaphylaxis groups as for controls (6.16 vs. 6.03 grams), because untreated calves needed more therapeutic interventions.
With that said, we haven’t painted the entire picture. The measure also matters: when antimicrobial use is counted as number of treatments per head rather than grams of active ingredient, metaphylaxis can increase total use, particularly when disease pressure is low.
It is also important to remember that drug choice matters. One study found that florfenicol (Nuflor) metaphylaxis increased the number of cattle treated once for BRD by 23.1% versus negative control, while tulathromycin (Draxxin) and ceftiofur (Naxcel) outperformed it. It is important to consult with you veterinarian to choose the drug that will perform the best for your operation.
The antimicrobial resistance trade-off.
Resistance is where the pressure on metaphylaxis becomes most concrete. Producer sentiment reflects the concern: in a 2026 DCHA conference session on dairy calf and heifer rearing, 67% of attendees reported switching antibiotics because one stopped working for BRD, and research on antimicrobial resistance in dairy calves is accelerating, with nearly 900 publications in early 2026 alone.
This study captures the dilemma perfectly. In 80 beef heifers, metaphylaxis upon arrival with tulathromycin (Draxxin) was compared with no treatment. Notably, arrival swabs taken before any antibiotics showed Mannheimia haemolytica already carried resistance genes, particularly to tetracyclines and phenicols. Three weeks later, metaphylaxis-treated calves showed a significantly higher prevalence of multi-drug resistant M. haemolytica—yet the treated group still had better health and performance.
In a nutshell this is the trade-off: metaphylaxis may drive resistance, yet it clearly benefits welfare and performance. Ignoring either side of that equation is a mistake.
Not every load brings the same risk.
One obstacle to more selective antibiotic use is that BRD risk varies—not just between sources, but also between groups and seasons. Sale-barn cattle are generally considered higher risk, yet sourcing alone does not reliably predict every group's health outcome.
Most high-risk and many medium-risk cattle currently receive metaphylaxis, while lower-risk cattle—heavier animals coming off grass or single-source cattle from backgrounding programs—may not. These distinctions already help feedlots target treatment at the group level. The harder task is determining which individual animals within an at-risk group need it.
Can technology help identify the cattle that need treatment?
Kansas State University extension veterinarian A.J. Tarpoff describes several approaches researchers are exploring to make treatment decisions more precise:
1. Rapid blood testing to assess indicators such as white blood cell counts.
2. Lung auscultation, using trained listeners or machine-learning-assisted systems.
3. Ultrasound, including research into its usefulness for predicting chronic cases.
4. Predictive models that combine multiple measurements rather than relying on one indicator.
The intent is straightforward: identify cattle most likely to benefit from treatment while reducing unnecessary drug use. But promising technology is not the same as a proven replacement for an established health program—these tools still need validation and have practical-use limitations.
Stewardship includes protecting cattle from infection.
The evidence points toward a nuanced conclusion rather than a simple one. Metaphylaxis reduces sickness and death, improves early growth, and can hold total antibiotic mass steady in high-morbidity groups. At the same time, it can select for multi-drug resistant pathogens and may increase total treatments per head depending on what drug is used and how much disease pressure really exists.
For producers and veterinarians, the need is for program refinement: evaluate cattle risk, address the management challenges surrounding arrival, and assess new tools.
Metaphylaxis remains an important option today; the opportunity ahead is to become more precise about which cattle need it while preserving its benefits for health and welfare. A receiving or treatment program cannot focus on pathogens alone—it also must account for the animal's ability to respond to those challenges.
Opportunity for the future.
New age nutraceuticals provide a promising hope for a decrease in the need for antimicrobials. One example is TomaHawk iL Zn which was fed to beef-cross calves during the milk feeding phase. Calves receiving TomaHawk iL Zn had 15.4% reduction in BRD incidence and a 3.67% decrease in treated animals within the group that relapsed and needed a second treatment. Resulting in a 3.56% decrease in mortality and a $5.34 per head economic advantage when compared to the control group.
It may prove that products like TomaHawk iL Zn would show similar results in newly received feedlot calves and weaned dairy calves. There is opportunity to decrease antimicrobial use in the future, it will just take some willingness to learn and determination for application on the part of the industry and livestock producers.
Find out more about TomaHawk iL Zn in the Calf Distinction store.
Written by: Mariah Gull, M.S.
Sources:
https://www.sciencedirect.com/science/article/pii/S2590286520300446 https://pmc.ncbi.nlm.nih.gov/articles/PMC9673257/ https://pmc.ncbi.nlm.nih.gov/articles/PMC11117203/ https://www.appliedanimalscience.org/article/S2590-2865(20)30153-1/fulltext https://www.sciencedirect.com/science/article/pii/S2590286523000630 https://pmc.ncbi.nlm.nih.gov/articles/PMC9697601/ https://digitalcommons.unl.edu/cgi/viewcontent.cgi?article=2222&context=animalscifacpub https://www.ars.usda.gov/research/publications/publication/?seqNo115=422541 https://trace.tennessee.edu/cgi/viewcontent.cgi?article=8032&context=utk_gradthes https://academic.oup.com/tas/article/doi/10.1093/tas/txag152/8865141 https://pmc.ncbi.nlm.nih.gov/articles/PMC9030209/pdf/skac067.pdf https://www.mdpi.com/2076-2615/14/10/1423 https://pmc.ncbi.nlm.nih.gov/articles/PMC10941641/ https://onlinelibrary.wiley.com/doi/full/10.1111/avj.13239 https://www.appliedanimalscience.org/article/S2590-2865(20)30044-6/pdf https://academic.oup.com/jas/article/doi/10.1093/jas/skad417/7486235 https://www.appliedanimalscience.org/article/S2590-2865(23)00063-0/pdf https://academic.oup.com/jas/article/100/4/skac067/6542850 https://scholar.google.com/citations?user=-NkAVycAAAAJ&hl=en https://extension.okstate.edu/programs/beef-extension/beef-cattle-research-updates/site-files/docs/archive/2020/bee f_cattle_research_update_october_2020-1.pdf https://pmc.ncbi.nlm.nih.gov/articles/PMC11677586